Citation

85 FR 5448

Canonical document for this Federal Register citation.

Testing of Retroviral Vector-Based Human Gene Therapy Products for Replication Competent Retrovirus During Product Manufacture and Patient Follow-up; Guidance for Industry; Availability Thursday, January 30, 2020 85 FR 5448